IVZ
Price
$26.51Alerts
Change
-$1.26 (-4.54%)
Updated
Nov 20 closing price
Capitalization
11.96B
65 days until earnings call
Intraday BUY SELL Signals
NTRS
Price
$162.20Alerts
Change
-$4.51 (-2.71%)
Updated
Nov 20 closing price
Capitalization
31.61B
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IVZ vs NTRS

IVZ vs NTRS Comparison Chart in %
View a ticker or compare two or three
A.I.Advisor
Oct 19, 2026

Which Stock Would AI Choose? Invesco (IVZ) vs. Northern Trust (NTRS) Stock Comparison

Key Takeaways

  • IVZ is a global asset manager whose assets under management (AUM) reached a record of roughly $2.17 trillion, up 17.5% year over year, supported by long-term net inflows of about $19.1 billion in its latest quarter.
  • NTRS is a diversified financial holding company spanning wealth management, asset servicing, and asset management, with assets under custody and administration near $17.4 trillion.
  • IVZ delivered stronger recent share-price momentum, ranking among the top-performing S&P 500 asset managers in 2025, while NTRS offered more measured gains and steady fee-driven earnings growth.
  • A sizable non-cash impairment pushed IVZ to a GAAP net loss in its latest quarter, contrasting with NTRS's consistent profitability and rising return on equity.
  • NTRS raised its medium-term pre-tax margin and return targets, whereas IVZ's near-term narrative centers on margin expansion and capital returns after a loss-making year.
  • Investors comparing the two are weighing growth-oriented asset-gathering momentum against the stability of a custody-and-wealth franchise.

Introduction

Invesco Ltd. (IVZ) and Northern Trust Corporation (NTRS) both operate at the center of the asset-management and financial-services ecosystem, yet they pursue very different business models. Invesco is primarily an investment manager focused on gathering assets across mutual funds, exchange-traded funds (ETFs), and alternatives. Northern Trust pairs asset and wealth management with a large custody and asset-servicing platform for institutions and ultra-high-net-worth families. This stock comparison is relevant for traders and investors evaluating relative performance, growth drivers, and risk profiles across two companies whose fortunes are closely tied to market levels, client flows, and interest rates.

IVZ Overview and Recent Performance

Invesco is one of the world's leading asset managers, with roots dating back to 1935 and a product lineup spanning equities, fixed income, alternatives, and multi-asset strategies. Its reach is global, with a meaningful share of client AUM held outside the United States. In recent weeks, the company has been in focus following its fourth-quarter 2025 results, which showed adjusted net revenue rising 8.8% year over year to about $1.26 billion and adjusted operating margin expanding to 36.4% from 33.7% a year earlier.

The stock has exhibited strong recent momentum, rallying more than 50% during 2025 and outperforming both the broader S&P 500 and much of the asset-management peer group. Sentiment has been supported by record AUM, long-term net inflows, the completed conversion of the Invesco QQQ Trust from a unit investment trust into an open-end ETF, and portfolio streamlining through divestitures. However, a roughly $1.8 billion non-cash intangible impairment charge pushed the company to a GAAP (Generally Accepted Accounting Principles) net loss for the quarter and full year, tempering the otherwise upbeat operating picture.

NTRS Overview and Recent Performance

Northern Trust is a financial holding company serving corporations, institutions, families, and individuals through three segments: Wealth Management, Asset Servicing, and Asset Management. Its asset-servicing franchise is among the largest globally, with assets under custody and administration of roughly $17.4 trillion, up about 11% year over year, and it counts a substantial share of top U.S. pension and healthcare plans among its clients. Wealth Management AUM grew about 13% to approximately $507 billion, while Asset Management AUM rose about 12% to around $1.8 trillion.

In its most recent quarter, NTRS reported earnings per share of $2.42, up 7% year over year and ahead of analyst expectations, on revenue of about $2.14 billion. Trust fee growth, higher net interest income, and disciplined expense management drove positive operating leverage. Management expressed enough confidence to raise medium-term targets, including a pre-tax margin goal near 33% and a mid-teens return on equity. The company maintained a Common Equity Tier 1 (CET1) capital ratio of 12.6% and returned roughly $1.9 billion to shareholders during 2025 through buybacks and dividends.

Trending AI Robots

Tickeron operates hundreds of AI Trading Bots that collectively trade thousands of different tickers, each built around its own trading style, strategy, timeframe, performance statistics, and universe of symbols. Because not every bot suits every market environment, Tickeron curates only the strongest and most appropriate strategies into its Trending AI Robots section, where traders can review current performance data and monitor how different automated approaches are positioned. This curated selection makes it easier to compare bots by their risk profiles, trade frequency, and recent results rather than sifting through the full catalog manually. Explore the Trending AI Robots page to see which automated strategies are currently favored by market conditions.

Head-to-Head Comparison

The clearest contrast between the two companies is their business mix. Invesco is an asset gatherer whose revenue scales with AUM and product flows, making it more sensitive to market appreciation and fund-level fee trends. Northern Trust blends fee-based custody and wealth services with a banking and net-interest-income component, giving it a steadier, more diversified revenue base.

On growth, IVZ has shown faster near-term momentum in both asset growth and share price, while NTRS has delivered more consistent earnings and profitability. IVZ's adjusted operating margin is structurally higher, but its recent GAAP loss highlights earnings-quality considerations. NTRS carries a lower, more stable earnings trajectory and stronger capital buffers, reflected in its CET1 ratio. Risk profiles differ accordingly: IVZ is more exposed to market volatility and fund flows, whereas NTRS is more exposed to interest rates and institutional fee pressure.

Market sentiment has favored IVZ's turnaround and asset-growth story, with recent analyst upgrades, while NTRS draws more mixed ratings despite a positive earnings reaction. Both companies are active capital returners, though NTRS's profitability supports its buybacks more comfortably than IVZ's loss-affected results.

Tickeron AI Verdict

Based on observable trend consistency, relative stability, and catalyst quality, Tickeron's AI would likely tilt toward NTRS for its steadier earnings profile, stronger capital position, and self-reinforcing fee-based model, which tend to produce more reliable trend signals. That said, IVZ presents a higher-momentum, higher-beta profile that may appeal to models oriented toward relative strength and asset-growth catalysts. The probabilistic assessment is that NTRS currently offers a more consistent risk-adjusted setup, while IVZ offers greater potential upside tied to sustained inflows and margin execution, making the choice dependent on an investor's preference for stability versus momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

VS
IVZ vs. NTRS commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVZ is a Hold and NTRS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IVZ with price predictions
Nov 20, 2026

IVZ in -7.47% downward trend, declining for three consecutive days on November 20, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IVZ declined for three days, in 201 of 287 cases, the price declined further within the following month. The odds of a continued downward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 37 of 56 cases where IVZ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 66%.

The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In 58 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for IVZ turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 31 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

The Aroon Indicator for IVZ entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IVZ's RSI Indicator exited the oversold zone, 20 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.

Following a +6.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in 227 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 55 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. IVZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.200) is normal, around the industry mean (2.423). IVZ has a moderately low P/E Ratio (-40.418) as compared to the industry average of (8.341). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (1.318). Dividend Yield (0.032) settles around the average of (0.274) among similar stocks. P/S Ratio (1.981) is also within normal values, averaging (15.906).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

A.I.Advisor
a Summary for NTRS with price predictions
Nov 20, 2026

NTRS in downward trend: price dove below 50-day moving average on November 17, 2026

NTRS moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend. In 28 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTRS as a result. In 47 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 55%.

The Moving Average Convergence Divergence Histogram (MACD) for NTRS turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 24 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NTRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NTRS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for NTRS crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 40%.

Following a +0.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTRS advanced for three days, in 201 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

NTRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 169 of 266 cases where NTRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 9 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 40 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. NTRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.525) is normal, around the industry mean (2.423). P/E Ratio (14.766) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.988) is also within normal values, averaging (1.318). Dividend Yield (0.020) settles around the average of (0.274) among similar stocks. P/S Ratio (3.888) is also within normal values, averaging (15.906).

FUNDAMENTALS RATINGS
IVZ vs NTRS: Fundamental Ratings
IVZ
NTRS
OUTLOOK RATING
1..100
8050
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
5540
SMR RATING
1..100
929
PRICE GROWTH RATING
1..100
5752
P/E GROWTH RATING
1..100
10047
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IVZ's Valuation (75) in the Investment Managers industry is in the same range as NTRS (87) in the Regional Banks industry. This means that IVZ’s stock grew similarly to NTRS’s over the last 12 months.

NTRS's Profit vs Risk Rating (40) in the Regional Banks industry is in the same range as IVZ (55) in the Investment Managers industry. This means that NTRS’s stock grew similarly to IVZ’s over the last 12 months.

NTRS's SMR Rating (9) in the Regional Banks industry is significantly better than the same rating for IVZ (92) in the Investment Managers industry. This means that NTRS’s stock grew significantly faster than IVZ’s over the last 12 months.

NTRS's Price Growth Rating (52) in the Regional Banks industry is in the same range as IVZ (57) in the Investment Managers industry. This means that NTRS’s stock grew similarly to IVZ’s over the last 12 months.

NTRS's P/E Growth Rating (47) in the Regional Banks industry is somewhat better than the same rating for IVZ (100) in the Investment Managers industry. This means that NTRS’s stock grew somewhat faster than IVZ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IVZNTRS
RSI
ODDS (%)
Bullish Trend 6 days ago
63%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
55%
MACD
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 18 days ago
68%
Bullish Trend 11 days ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
64%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (IVZ: $26.51 vs. NTRS: $162.20)
Brand notoriety: IVZ and NTRS are both not notable
Both companies represent the Investment Managers industry
Current volume relative to the 65-day Moving Average: IVZ: 141% vs. NTRS: 173%
Market capitalization -- IVZ: $11.96B vs. NTRS: $31.61B
IVZ [@Investment Managers] is valued at $11.96B. NTRS’s [@Investment Managers] market capitalization is $31.61B. The market cap for tickers in the [@Investment Managers] industry ranges from $1.6 to $182.57B. The average market capitalization across the [@Investment Managers] industry is $8.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVZ’s FA Score shows that 0 FA rating(s) are green while NTRS’s FA Score has 1 green FA rating(s).

  • IVZ’s FA Score: 0 green, 5 red.
  • NTRS’s FA Score: 1 green, 4 red.
According to our system of comparison, NTRS is a better buy in the long-term than IVZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVZ’s TA Score shows that 3 TA indicator(s) are bullish while NTRS’s TA Score has 6 bullish TA indicator(s).

  • IVZ’s TA Score: 3 bullish, 5 bearish.
  • NTRS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NTRS is a better buy in the short-term than IVZ.

Price Growth

IVZ (@Investment Managers) experienced а -8.33% price change this week, while NTRS (@Investment Managers) price change was -9.00% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -8.27%. For the same industry, the average monthly price growth was -9.09%, and the average quarterly price growth was -10.90%.

Reported Earning Dates

IVZ is expected to report earnings on Jan 26, 2027.

NTRS is expected to report earnings on Jan 21, 2027.

Industries' Descriptions

@Investment Managers (-8.27% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

View a ticker or compare two or three
Interact to see
Advertisement

IVZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVZ has been closely correlated with BLK. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then BLK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVZ
1D Price
Change %
IVZ100%
-4.54%
BLK - IVZ
70%
Closely correlated
-3.00%
BEN - IVZ
70%
Closely correlated
-3.70%
CG - IVZ
68%
Closely correlated
-4.43%
STT - IVZ
64%
Loosely correlated
-3.63%
BN - IVZ
59%
Loosely correlated
-3.06%
More

NTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRS has been closely correlated with STT. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTRS jumps, then STT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRS
1D Price
Change %
NTRS100%
-2.71%
STT - NTRS
78%
Closely correlated
-3.63%
RJF - NTRS
60%
Loosely correlated
-1.93%
AMP - NTRS
58%
Loosely correlated
-2.45%
IVZ - NTRS
56%
Loosely correlated
-4.54%
BLK - NTRS
51%
Loosely correlated
-3.00%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDLS8.36-0.10
-1.18%
Noodles & Co
NGNE22.15-0.78
-3.40%
Neurogene
SMMT9.95-0.62
-5.87%
Summit Therapeutics
RUM4.19-0.40
-8.71%
RUM Group Inc
JUNS1.24-0.23
-15.41%
Jupiter Neurosciences Inc